logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Central alpha-2 Adrenergic Agonist class drugs

    FiltersReset Filters
    18 results

    • clonidine

      (clonidine)
      Ingenus Pharmaceuticals, LLC
      Usage: Clonidine hydrochloride extended-release tablets are indicated for the treatment of attention deficit hyperactivity disorder (ADHD), both as a monotherapy and as an adjunctive therapy to stimulant medications.

    • clonidine hydrochloride

      (Clonidine hydrochloride)
      Ajanta Pharma USA Inc.
      Usage: Clonidine hydrochloride extended-release is indicated for the treatment of attention deficit hyperactivity disorder (ADHD), both as a standalone therapy and as an adjunct to stimulant medications.

    • dexmedetomidine hydrochloride

      (DEXMEDETOMIDINE HYDROCHLORIDE)
      Baxter Healthcare Company
      Usage: Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation in mechanically ventilated adult patients in intensive care and for non-intubated adults during surgical or other procedures. It can be continuously infused during extubation without interruption prior to the procedure.

    • dexmedetomidine hydrochloride

      (DEXMEDETOMIDINE HYDROCHLORIDE)
      Baxter Healthcare Corporation
      Usage: Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation in adult patients who are intubated and mechanically ventilated in intensive care, as well as for procedural sedation in non-intubated adults during surgical and other procedures. Continuous infusion should not exceed 24 hours.

    • dexmedetomidine hydrochloride

      (Dexmedetomidine Hydrochloride)
      ENDO USA, Inc.
      Usage: Dexmedetomidine hydrochloride injection is indicated for sedation in mechanically ventilated adult ICU patients and for non-intubated adults during surgical or other procedures. It facilitates continuous sedation without the need for discontinuation prior to extubation, and has specific pediatric usage approved for another product.

    • dexmedetomidine hydrochloride in 0.9% sodium chloride

      (DEXMEDETOMIDINE HYDROCHLORIDE in 0.9% sodium chloride)
      Baxter Healthcare Corporation
      Usage: Dexmedetomidine hydrochloride in 0.9% sodium chloride injection is indicated for sedation in mechanically ventilated adult patients in intensive care and for non-intubated adult patients during surgical and other procedures. It can be used continuously during extubation without interruption. Pediatric use information exists but is not included in this product.

    • dexmedetomidine hydrochloride in sodium chloride

      (Dexmedetomidine Hydrochloride)
      Precision Dose, Inc.
      Usage: Dexmedetomidine HCl in 0.9% sodium chloride injection is indicated for sedation in mechanically ventilated adults in intensive care and for non-intubated adults undergoing surgical and other procedures. It can be administered continuously for up to 24 hours without needing to be discontinued before extubation.

    • guanfacine

      (guanfacine)
      Slate Run Pharmaceuticals, LLC
      Usage: Guanfacine Extended-Release Tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), both as a standalone therapy and alongside stimulant medications.

    • guanfacine

      (Guanfacine)
      PuraCap Laboratories LLC dba Blu Pharmaceuticals
      Usage: Guanfacine hydrochloride tablets are indicated for managing hypertension, either alone or in combination with other antihypertensive agents, particularly thiazide-type diuretics.

    • guanfacine

      (Guanfacine)
      Advagen Pharma Ltd
      Usage: Guanfacine tablets are indicated for managing hypertension, either as a standalone treatment or in combination with other antihypertensive medications, particularly thiazide-type diuretics.